Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human beta 1 Adrenergic Receptor ELISA Kit (AC2798)
Cat.#: ASET-1387
Specifications
Description Human beta 1 Adrenergic Receptor ELISA Kit allows for the in vitro quantitative determination of human beta 1 Adrenergic Receptor concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2401 Human FGF2 ELISA Kit (AC3812) Quantitative inquiry ASET-1207 Human ALDH1A1 ELISA Kit (AC2618) Quantitative inquiry ASET-1771 Rat Neuroglobin ELISA Kit (AC3182) Quantitative inquiry ASET-1269 Mouse Urocortin ELISA Kit (AC2680) Quantitative inquiry ASET-2201 Rat LC3B ELISA Kit (AC3612) Quantitative inquiry ASET-1244 Mouse NT-4 ELISA Kit (AC2655) Quantitative inquiry ASET-1731 Human CD45 ELISA Kit (AC3142) Quantitative inquiry ASET-1612 Human Nyctalopin ELISA Kit (AC3023) Quantitative inquiry ASET-1429 Human PMP22 ELISA Kit (AC2840) Quantitative inquiry ASET-1881 Human GJB2 ELISA Kit (AC3292) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket